Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98M Buy
88,805
+7,803
+10% +$520K 0.01% 964
2026
Q1
$5.09M Sell
81,002
-3,848
-5% -$268K 0.01% 1049
2025
Q4
$5.64M Buy
84,850
+40,654
+92% +$2.63M 0.01% 956
2025
Q3
$2.97M Sell
44,196
-764
-2% -$60.5K ﹤0.01% 1195
2025
Q2
$3.92M Buy
44,960
+8,082
+22% +$634K 0.01% 980
2025
Q1
$2.52M Buy
36,878
+7,149
+24% +$583K ﹤0.01% 1114
2024
Q4
$2.31M Buy
29,729
+442
+2% +$32.7K ﹤0.01% 1136
2024
Q3
$1.96M Sell
29,287
-61,496
-68% -$5.05M ﹤0.01% 1196
2024
Q2
$10.3M Buy
90,783
+6,531
+8% +$826K 0.02% 501
2024
Q1
$11.7M Buy
84,252
+45,439
+117% +$5.71M 0.02% 468
2023
Q4
$4.82M Buy
38,813
+4,295
+12% +$439K 0.01% 690
2023
Q3
$3.22M Buy
34,518
+2,186
+7% +$246K 0.01% 792
2023
Q2
$4.15M Buy
32,332
+966
+3% +$117K 0.01% 708
2023
Q1
$3.64M Buy
31,366
+1,406
+5% +$157K 0.01% 731
2022
Q4
$3.39M Buy
29,960
+2,441
+9% +$268K 0.01% 727
2022
Q3
$2.22M Buy
27,519
+7,432
+37% +$629K 0.01% 734
2022
Q2
$1.5M Buy
+20,087
New +$1.83M 0.01% 790
2019
Q3
Sell
-21,040
Closed -$788K 775
2019
Q2
$788K Buy
+21,040
New +$661K 0.01% 588

Other funds holding DXCM

Mariner's DXCM Position: Q2 2026 in Review

Mariner increased its DexCom (DXCM) stake by 9.6% in Q2 2026, buying an estimated $520K and bringing the position to 88,805 shares worth $5.98M. The position accounts for 0.01% of the portfolio, ranked #964.

Mariner first reported a position in DXCM in Q2 2019 and has held it in 18 quarters since. The position peaked at $11.7M in Q1 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Mariner held 88,805 shares of DexCom worth $5.98M as of Q2 2026.
  • Mariner bought 7,803 DexCom shares in Q2 2026, an estimated $520K.
  • DexCom made up 0.01% of Mariner's portfolio in Q2 2026, its #964 holding.
  • Mariner first reported a position in DexCom in Q2 2019 and has held it in 18 quarters since.
  • Mariner's DexCom position peaked at $11.7M in Q1 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.